Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIRx Med

Date Submitted: Feb 11, 2022
Date Accepted: Feb 11, 2022

The final, peer-reviewed published version of this preprint can be found here:

Authors' Response to Peer Reviews of “Cognitive Factors Associated With Public Acceptance of COVID-19 Nonpharmaceutical Prevention Measures: Cross-sectional Study”

Constant A, Conserve D, Gallopel-Morvan K, Raude J

Authors' Response to Peer Reviews of “Cognitive Factors Associated With Public Acceptance of COVID-19 Nonpharmaceutical Prevention Measures: Cross-sectional Study”

JMIRx Med 2022;3(2):e37241

DOI: 10.2196/37241

PMCID: 10414295

Authors' Responses to Peer Review Reports for MS# 32859 "Cognitive factors associated with Public acceptance of COVID-19 non-pharmaceutical prevention measures: Results from a cross sectional study in France"

  • Aymery Constant; 
  • Donaldson Conserve; 
  • Karine Gallopel-Morvan; 
  • Jocelyn Raude

ABSTRACT

This is a peer review report related to MS# 32859.


 Citation

Please cite as:

Constant A, Conserve D, Gallopel-Morvan K, Raude J

Authors' Response to Peer Reviews of “Cognitive Factors Associated With Public Acceptance of COVID-19 Nonpharmaceutical Prevention Measures: Cross-sectional Study”

JMIRx Med 2022;3(2):e37241

DOI: 10.2196/37241

PMCID: 10414295

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.